Medical Futurist points to in silico as future of pharma

Bertalan Meskó, MD, PhD, has written an article on Pharmaphorum about trends that will shape the future of pharma.
Future of Pharma

The author notes that the pharma industry should prepare for the digital health era. Performing in silico clinical trials is the future of medical innovations, and chances are real that small startup companies will play a major role in this – if pharma lags behind regarding digital healthcare.

The “medical futurist” points to 6 trends shaping the future of pharma:

  • Empowered patients – Patients find their own solution if their high expectations are not met.
  • Augmented and virtual reality – Visual explanations how drugs work in 3D, improved lab monitoring and intelligent devices are just a few examples.
  • Truly personalized medicine – Therapies (susceptibility for a certain medication, dosage, side effects etc) that are customized to our own genetic and metabolic profile instead of drugs for the ‘average’ patient.
  • 3D-printed drugs – Small companies can come up with innovative manufacturing solutions to reach the market more easily.
  • Body sensors – Automated collection of patient data during clinical trials would improve clinical trials substantially.
  • Artificial intelligence – Medical decisions made by cognitive computers based on analysis of big data instead of tests on actual people.

More information can be found here.


Gallery:

Future of Pharma

Date: 01/06/2016 | Tag: | News: 484 of 566
All news

News

More news

Events

More events
newsletter

Subscribe to the VPH Institute Newsletter

Are you...

A clinician?
A researcher?
A science curious?
An industrial?

Open subscribe

ARCHIVE

Read all the newsletters of the VPH Institute

GO